{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:09:48Z","timestamp":1781284188031,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.molimm.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T18:02:41Z","timestamp":1746727361000},"page":"72-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Knockdown of RRBP1 regulates endoplasmic reticulum stress to mitigate malignant progression and suppress bortezomib resistance of multiple myeloma cells by inhibiting GRP78 expression"],"prefix":"10.1016","volume":"183","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.05.001_bib1","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1158\/1078-0432.CCR-16-0625","article-title":"Progress and paradigms in multiple myeloma","volume":"22","author":"Anderson","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2025.05.001_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.72","article-title":"Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers","volume":"6","author":"Avril","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.molimm.2025.05.001_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720979813","article-title":"The role of belantamab mafodotin for patients with relapsed and\/or refractory multiple myeloma","volume":"11","author":"Becnel","year":"2020","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.molimm.2025.05.001_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101168","article-title":"Chromosomal defects in multiple myeloma","volume":"64","author":"Clarke","year":"2024","journal-title":"Blood Rev."},{"key":"10.1016\/j.molimm.2025.05.001_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.molimm.2025.05.001_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1069360","article-title":"Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: a real-life study","volume":"13","author":"Debureaux","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2025.05.001_bib7","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.celrep.2018.12.016","article-title":"Non-overlapping control of transcriptome by promoter- and super-enhancer-associated dependencies in multiple myeloma","volume":"25","author":"Fulciniti","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molimm.2025.05.001_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071174","article-title":"La autoantigen induces ribosome binding protein 1 (RRBP1) expression through internal ribosome entry site (IRES)-mediated translation during cellular stress condition","volume":"17","author":"Gao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2025.05.001_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10184179","article-title":"Occupational exposure and multiple myeloma risk: an updated review of meta-analyses","volume":"10","author":"Georgakopoulou","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.molimm.2025.05.001_bib10","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2020.34.s1.00037","article-title":"Glucose regulated protein (GRP78) as a biomarker of response to bortezomib-based regimen in multiple myeloma","volume":"34","author":"Gupta","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.molimm.2025.05.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117656","article-title":"High glucose may promote the proliferation and metastasis of hepatocellular carcinoma via E2F1\/RRBP1 pathway","volume":"252","author":"He","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.molimm.2025.05.001_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jdsr.2021.08.006","article-title":"Pathogenesis and treatment of multiple myeloma bone disease","volume":"57","author":"Hiasa","year":"2021","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"10.1016\/j.molimm.2025.05.001_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2019.10.030","article-title":"EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation","volume":"49","author":"Huang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molimm.2025.05.001_bib14","doi-asserted-by":"crossref","first-page":"10275","DOI":"10.18632\/aging.103239","article-title":"UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT","volume":"12","author":"Huang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.molimm.2025.05.001_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lfs.2019.04.022","article-title":"GRP78: a cell's response to stress","volume":"226","author":"Ibrahim","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.molimm.2025.05.001_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0968-0004(01)01908-9","article-title":"The glucose-regulated proteins: stress induction and clinical applications","volume":"26","author":"Lee","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molimm.2025.05.001_bib17","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.2147\/CMAR.S186632","article-title":"RRBP1 is highly expressed in prostate cancer and correlates with prognosis","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.molimm.2025.05.001_bib18","article-title":"Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response","volume":"118","author":"Lin","year":"2019","journal-title":"Biomed. Pharmacother. =\u2009Biomed. Pharmacother."},{"key":"10.1016\/j.molimm.2025.05.001_bib19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/bloodadvances.2020002578","article-title":"The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma","volume":"5","author":"Lipchick","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.molimm.2025.05.001_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13000-019-0784-6","article-title":"RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma","volume":"14","author":"Liu","year":"2019","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.molimm.2025.05.001_bib21","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.2147\/OTT.S252043","article-title":"Ribosome binding protein 1 correlates with prognosis and cell proliferation in bladder cancer","volume":"13","author":"Lv","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.molimm.2025.05.001_bib22","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1038\/s41375-020-0921-y","article-title":"Genome instability in multiple myeloma","volume":"34","author":"Neuse","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.molimm.2025.05.001_bib23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/17474086.2020.1830372","article-title":"Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma","volume":"13","author":"Ninkovic","year":"2020","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.molimm.2025.05.001_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1008265012435","article-title":"Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol","volume":"9","author":"Perego","year":"1998","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.molimm.2025.05.001_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.phrs.2017.02.018","article-title":"Unraveling the role of ER stress inhibitors in the context of metabolic diseases","volume":"119","author":"Sarvani","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molimm.2025.05.001_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","article-title":"UPR, autophagy, and mitochondria crosstalk underlies the ER stress response","volume":"40","author":"Senft","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molimm.2025.05.001_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.562","article-title":"Interleukin-33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species-mediated inhibition of nuclear factor kappa-B signal and stemness properties","volume":"5","author":"Shao","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.molimm.2025.05.001_bib28","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.2147\/OTT.S174640","article-title":"Update on elotuzumab for the treatment of relapsed\/refractory multiple myeloma: patients' selection and perspective","volume":"12","author":"Trudel","year":"2019","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.molimm.2025.05.001_bib29","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/onc.2012.514","article-title":"Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78","volume":"32","author":"Tsai","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2025.05.001_bib30","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/onc.2012.514","article-title":"Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78","volume":"32","author":"Tsai","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2025.05.001_bib31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/1535-7163.MCT-12-0782","article-title":"Endoplasmic reticulum stress and the unfolded protein response: targeting the achilles heel of multiple myeloma","volume":"12","author":"Vincenz","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.molimm.2025.05.001_bib32","doi-asserted-by":"crossref","first-page":"43602","DOI":"10.18632\/oncotarget.17115","article-title":"Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress","volume":"8","author":"Wallington-Beddoe","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.molimm.2025.05.001_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215340","article-title":"Looking into endoplasmic reticulum stress: the key to drug-resistance of multiple myeloma?","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.molimm.2025.05.001_bib34","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.7150\/jca.30102","article-title":"High numbers of CD163+\u2009tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.molimm.2025.05.001_bib35","first-page":"203","article-title":"RRBP1 is highly expressed in bladder cancer and is associated with migration and invasion","volume":"20","author":"Wang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.molimm.2025.05.001_bib36","first-page":"16","article-title":"cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance","volume":"8","author":"Wang","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.molimm.2025.05.001_bib37","article-title":"USP35 mitigates endoplasmic reticulum stress-induced apoptosis by stabilizing RRBP1 in non-small cell lung cancer","volume":"n\/a","author":"Wang","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.molimm.2025.05.001_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/leu.2013.233","article-title":"Transcription factor-pathway coexpression analysis reveals cooperation between SP1 and ESR1 on dysregulating cell cycle arrest in non-hyperdiploid multiple myeloma","volume":"28","author":"Wang","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.molimm.2025.05.001_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-021-02786-6","article-title":"GRP78 in lung cancer","volume":"19","author":"Xia","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molimm.2025.05.001_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-021-02786-6","article-title":"GRP78 in lung cancer","volume":"19","author":"Xia","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molimm.2025.05.001_bib41","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1172\/JCI26373","article-title":"J.C. Reed, Endoplasmic reticulum stress: cell life and death decisions","volume":"115","author":"Xu","year":"2005","journal-title":"J. Clin. Investig."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:23:41Z","timestamp":1762248221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"alternative-id":["S0161589025001154"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.05.001","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knockdown of RRBP1 regulates endoplasmic reticulum stress to mitigate malignant progression and suppress bortezomib resistance of multiple myeloma cells by inhibiting GRP78 expression","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}